Dabigatran 13C6
| Product Name | Dabigatran 13C6 |
|---|---|
| Alternate Names | Dabigatran Stable Isotopes, Stable Isotopes of Dabigatran |
| CAT No. | CS-O-06521 |
| CAS No. | 1210608-88-0 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 477.5 g/mol |
| Mol. For. | C1913C6H25N7O3 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Dabigatran |
| Purity | 95% |
| Therapeutic | Anti-Thrombotics |
| Smileys | CN1C2=CC=C(C(N(C3=CC=CC=N3)CCC(O)=O)=O)C=C2N=C1CN[13C]4=[13CH][13CH]=[13C](C(N)=N)[13CH]=[13CH]4 |
| Canonical Smiles | CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N |
| InchIKey | YBSJFWOBGCMAKL-WLDHFFRPSA-N |
| Inchl | InChI=1S/C25H25N7O3/c1-31-20-10-7-17(25(35)32(13-11-23(33)34)21-4-2-3-12-28-21)14-19(20)30-22(31)15-29-18-8-5-16(6-9-18)24(26)27/h2-10,12,14,29H,11,13,15H2,1H3,(H3,26,27)(H,33,34)/i5+1,6+1,8+1,9+1,16+1,18+1 |
| IUPAC | 3-[[2-[[(4-carbamimidoyl(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)amino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Dabigatran 13C6 is a medication used to reduce the risk of stroke and blood clots in people with atrial fibrillation, a type of irregular heartbeat. It belongs to a class of medications called direct thrombin inhibitors, which work by inhibiting the activity of thrombin, an enzyme responsible for blood clot formation. Dabigatran 13C6 is a modified version of dabigatran, with six of the carbon atoms replaced with the stable isotope carbon-13, which is useful for research purposes.
The chemical formula of dabigatran 13C6 is C34H28C6N6O8, and its molecular weight is 706.77 g/mol. It is available as an oral capsule in strengths of 75 mg and 150 mg. The recommended dose of dabigatran 13C6 is usually based on a person's age, weight, and kidney function.
Dabigatran 13C6 has a half-life of around 12-14 hours, meaning it takes this amount of time for half of the drug to be eliminated from the body. It is primarily eliminated through the kidneys, and caution should be exercised in people with impaired kidney function.
Common side effects of dabigatran 13C6 include bleeding, gastrointestinal upset, and skin rash. It may also interact with other medications, so it is important to inform your healthcare provider of all medications you are taking before starting dabigatran 13C6.
Get an Instant Quote
Related Compounds
Dabigatran D4 DCl | Dabigatran D7 | N-Nitroso Dabigatran Etexilate 13C6 | N-Nitroso Dabigatran Etexilate-d11 | Deacetamidine Cyano Dabigatran-d3 Ethyl Ester | Dabigatran β-Acyl Glucuronide D4 | Dabigatran D4 Etexilate | Dabigatran D4 HCl | N-Nitroso Dabigatran-d4 Etexilate | Dabigatran Acyl-ß-D-glucuronide D3 trifluoroacetate salt | Deacetamidine Cyano Dabigatran-d3 Ethyl Ester Oxalate | Dabigatran-d4 | Dabigatran Acyl-β-D-Glucuronide 13C6 |